PRESS RELEASES

March 2008

Complications From Heartburn on the Rise 

May 2007

Presentation of Long-term Results for Treating Barrett’s Esophagus with HALO Ablation System 

Genetic Abnormalities Associated with Esophageal Cancer Eliminated after Treatment with HALO Ablation System (Presented by Jacques Bergman, MD 2007 Digestive Disease Week) 

March 2007

Publication of Long-term Results for Treating Barrett’s Esophagus with HALO³⁶⁰ Ablation System 

July 2006

BÂRRX Medical, Inc. Secures $27.8 Million Series C Venture Funding  

May 2006

Nine Clinical Studies Evaluating Safety and Efficacy of HALO³⁶⁰ and HALO⁹⁰ Systems to Treat Barrett's Esophagus Presented at Digestive Disease Week 

April 2006

BÂRRX Medical, Inc. Announces FDA Clearance of the HALO⁹⁰ System 

Investigators To Present Positive Clinical Trial Results Underscoring the Efficacy of BÂRRX Medical's Ablation Systems for Barrett's Esophagus 

March 2006

BÂRRX Medical, Inc. Acquires Intellectual Property Rights for Barrett's Esophagus, Expands Portfolio 

BÂRRX Medical, Inc. Initiates Landmark Study Comparing Two Treatment Options for Barrett's Esophagus 

BÂRRX Medical, Inc. Introduces New Minimally Invasive Tool for Treating Barrett's Esophagus 

January 2006

Surgical Endoscopy Publishes Data Evaluating Dosing and Ablation Depth of the HALO³⁶⁰ System in the Human Esophagus: A Technology Relevant as a Current Treatment for Barrett's Esophagus 

November 2005

Professional Society Urges Certain Patients with Chronic GERD to Seek Screening for Barrett's Esophagus 

October 2005

Data Evaluating Safety and Efficacy of the HALO³⁶⁰ System in Treating Barrett's Esophagus Presented at the American College of Gastroenterology Annual Meeting 

May 2005

Data Evaluating Safety and Efficacy of the HALO³⁶⁰ System in Treating Barrett's Esophagus